DRAFT FOR REVIEW
Comment period for this initial draft ends on May 1, 2020.
You may provide comments, proposed edits, or other suggestions for future versions of this Guide on our dedicated feedback site. If you have questions or need help unrelated to this guide, please see the Contact LOINC page.
This work was supported by the U.S. Food and Drug Administration contract 75F40119C10140.
Download DRAFT • PDF • 717 KB